Finance

Lists
Why is BRTX down 5,66%?
Dive Deeper
BRTX:NASDAQ
BioRestorative Therapies Inc
1,50 US$
-5,66%
(-0,090) 1D
14 ოქტ, 12:03:13 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRTX...
Open
1,50 US$
High
1,56 US$
Low
1,42 US$
Mkt. cap
2,07 მლნ.
Avg. vol.
197,44 ათ.
Volume
8,83 ათ.
52-wk high
34,40 US$
52-wk low
1,42 US$
EPS
-21,76 US$
Beta
0,85
Shares outstanding
1,38 მლნ.
No. of employees
14
Open
1,50 US$
High
1,56 US$
Low
1,42 US$
Mkt. cap
2,07 მლნ.
Avg. vol.
197,44 ათ.
Volume
8,83 ათ.
52-wk high
34,40 US$
52-wk low
1,42 US$
EPS
-21,76 US$
Beta
0,85
Shares outstanding
1,38 მლნ.
No. of employees
14
News stories
From web sources and news partners
About BioRestorative Therapies Inc
CEO-
Employees14
Founded1997
Headquarters-
Sector-
Websitebiorestorative.com
Analyst ratings
Based on 1 analyst giving stock ratings to BRTX in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for BRTX in the last 3 months
Highest
Current 1,50 US$
(-100,00%)
Average
(-100,00%)
Lowest
(-100,00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Hold
Downgraded
-
-
10/06/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
15,00 US$
+900%
04/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
303,30 ათ.
11,80 ათ.
19,60 ათ.
23,17 ათ.
Cost of goods sold
8,73 ათ.
10,57 ათ.
1,64 ათ.
7,38 ათ.
Cost of revenue
8,73 ათ.
10,57 ათ.
1,64 ათ.
7,38 ათ.
Research and development expenses
2,23 მლნ.
2,59 მლნ.
2,63 მლნ.
1,93 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,37 მლნ.
1,12 მლნ.
1,22 მლნ.
1,48 მლნ.
Operating expense
3,60 მლნ.
3,71 მლნ.
3,84 მლნ.
3,40 მლნ.
Total operating expenses
3,61 მლნ.
3,72 მლნ.
3,84 მლნ.
3,41 მლნ.
Operating income
-3,31 მლნ.
-3,71 მლნ.
-3,83 მლნ.
-3,39 მლნ.
Other non operating income
575,11 ათ.
612,99 ათ.
583,08 ათ.
1,23 მლნ.
EBT including unusual items
-2,66 მლნ.
-3,04 მლნ.
-3,21 მლნ.
-2,15 მლნ.
EBT excluding unusual items
-2,66 მლნ.
-3,04 მლნ.
-3,21 მლნ.
-2,15 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,66 მლნ.
-3,04 მლნ.
-3,21 მლნ.
-2,15 მლნ.
Net profit margin
-875,79%
-25 748,11%
-16 365,49%
-9 298,25%
Earnings per share
-6,00
-6,60
-6,40
-2,40
Interest and investment income
73,92 ათ.
57,74 ათ.
34,59 ათ.
5,48 ათ.
Interest expense
-
-
-
-
Net interest expenses
73,92 ათ.
57,74 ათ.
34,59 ათ.
5,48 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,25 მლნ.
-3,66 მლნ.
-3,77 მლნ.
-3,33 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები